leucine has been researched along with Mucocutaneous Lymph Node Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agostini, H; Belot, A; Boukhedouni, N; Dusser, P; Foell, D; Fuehner, S; Kessel, C; Koné-Paut, I; Marie, I; Masjosthusmann, K; Piedvache, C; Rossi-Semerano, L; Tellier, S; Wittkowski, H | 1 |
1 other study(ies) available for leucine and Mucocutaneous Lymph Node Syndrome
| Article | Year |
|---|---|
An Immunological Axis Involving Interleukin 1β and Leucine-Rich-α2-Glycoprotein Reflects Therapeutic Response of Children with Kawasaki Disease: Implications from the KAWAKINRA Trial.
Topics: Biomarkers; Child; Endothelial Cells; Glycoproteins; Humans; Immunoglobulins, Intravenous; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Interleukin-6; Leucine; Mucocutaneous Lymph Node Syndrome; Retrospective Studies; S100A12 Protein | 2022 |